{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:19:56Z","timestamp":1787750396690,"version":"build-2784847793"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Spinal muscular atrophy (SMA) is a genetic disorder resulting in progressive muscle atrophy due to the degradation of motor neurons. There are limited data on anesthesia care for these patients, the incidence of anesthesia-related adverse events, and difficult intubations. The investigators aim to characterize patients with SMA who required anesthetics at a large quaternary pediatric hospital, describe the procedures being performed, report the incidence of severe anesthesia\u2013related adverse events, and determine the incidence of difficult intubations. The investigators hypothesized that lumbar puncture for nusinersen administration would represent the most common procedure for which patients with SMA required anesthesia care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>A retrospective chart review of anesthetics provided to SMA patients from June 1, 2012, to December 30, 2023. Data obtained included procedures performed, patient characteristics, perioperative care, anesthesia technique, and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      In total, 1804 procedures were performed for 175 patients with SMA. The majority of procedures (1423\/1804, 78.9%) were for lumbar puncture for nusinersen administration; 234 of 1804 (13.0%) received general anesthesia with endotracheal tube placement; 22 of 1804 total cases (1.2%) or 22 of 234 (9.4%) of those with endotracheal tube placement met the definition of difficult intubation. There were no statistically significant associations between difficult intubation and SMA type, age, and presence of halo headframe (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; .05). There were six severe anesthesia\u2013related adverse events (0.33%). Of 1423 total procedures for lumbar punctures for nusinersen administration, 1254 of 1423 (88.1%) were performed with a natural airway (nasal canula, facemask, or home continuous positive airway pressure [CPAP] or biphasic positive airway pressure [BiPAP]) or pre-existing tracheostomy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Lumbar puncture for nusinersen administration made up the vast majority of procedures for which patients with SMA presented for anesthesia care. The incidence of difficult intubation was 9.4%, and the incidence of anesthesia-related severe adverse events was 0.33%. These results indicate the need to focus research on the perioperative and airway-related risks for this evolving and medically complex population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000008155","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T14:00:10Z","timestamp":1782568810000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Anesthesia Care, Complications, and Airway Management for Patients With Spinal Muscular Atrophy: A Retrospective Chart Review From a Quaternary Children\u2019s Hospital"],"prefix":"10.1213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8016-6139","authenticated-orcid":false,"given":"Kathryn M.","family":"Black","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7588-7596","authenticated-orcid":false,"given":"Steven J.","family":"Staffa","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children\u2019s Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"van Pelt","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children\u2019s Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0629-6511","authenticated-orcid":false,"given":"Joseph P.","family":"Cravero","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children\u2019s Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"R1-20260627","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene.","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"R2-20260627","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/pan.12159","article-title":"Anesthesia and spinal muscle atrophy.","volume":"23","author":"Islander","year":"2013","journal-title":"Paediatr Anaesth"},{"key":"R3-20260627","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2011.09.001","article-title":"Spinal muscular atrophy: a clinical and research update.","volume":"46","author":"Markowitz","year":"2012","journal-title":"Pediatr Neurol"},{"key":"R4-20260627","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/MOP.0000000000001403","article-title":"Treatment of spinal muscular atrophy.","volume":"36","author":"Pera","year":"2024","journal-title":"Curr Opin Pediatr"},{"key":"R5-20260627","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy.","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med"},{"key":"R6-20260627","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus sham control in later-onset spinal muscular atrophy.","volume":"378","author":"Mercuri","year":"2018","journal-title":"N Engl J Med"},{"key":"R7-20260627","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy.","volume":"86","author":"Chiriboga","year":"2016","journal-title":"Neurology"},{"key":"R8-20260627","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study.","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet"},{"key":"R9-20260627","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13023-025-03603-9","article-title":"Real-world analysis of the efficacy and safety of nusinersen in pediatric patients with spinal muscular atrophy.","volume":"20","author":"Li","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"R10-20260627","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s41983-025-00959-4","article-title":"The efficacy and safety of nusinersen for spinal muscular atrophy types 1, 2, 3: a systematic review of the current evidence.","volume":"61","author":"Daghriri","year":"2025","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"key":"R11-20260627","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1055\/a-2379-7069","article-title":"Effect of nusinersen on respiratory and bulbar function in children with spinal muscular atrophy: real-world experience from a single center.","volume":"56","author":"Gaboli","year":"2025","journal-title":"Neuropediatrics"},{"key":"R12-20260627","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/bcp.15718","article-title":"Procedural sedation for paediatric patients with spinal muscular atrophy undergoing intrathecal treatment.","volume":"89","author":"Sever","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"R13-20260627","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/pan.13964","article-title":"Anesthetic management of pediatric patients undergoing intrathecal nusinersen administration for treatment of spinal muscular atrophy: a single-center experience.","volume":"31","author":"Brollier","year":"2021","journal-title":"Paediatr Anaesth"},{"key":"R14-20260627","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/pan.13500","article-title":"A retrospective cohort study of children with spinal muscular atrophy type 2 receiving anesthesia for intrathecal administration of nusinersen.","volume":"28","author":"Bielsky","year":"2018","journal-title":"Paediatr Anaesth"},{"key":"R15-20260627","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/pan.14630","article-title":"Needleless inhaled anesthesia with sevoflurane: advantages of a simplified approach for children with spinal muscular atrophy undergoing intrathecal administration of nusinersen.","volume":"33","author":"Salerno","year":"2023","journal-title":"Paediatr Anaesth"},{"key":"R16-20260627","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/aas.14011","article-title":"Anaesthetic considerations in posterior instrumentation of scoliosis due to spinal muscular atrophy: case series of 56 operated patients.","volume":"66","author":"F\u00f6rster","year":"2022","journal-title":"Acta Anaesthesiol Scand"},{"key":"R17-20260627","doi-asserted-by":"crossref","first-page":"e12138","DOI":"10.1002\/anr3.12138","article-title":"A case series of paediatric patients with spinal muscular atrophy type I undergoing scoliosis correction surgery.","volume":"9","author":"Kong Kam Wa","year":"2021","journal-title":"Anaesth Rep"},{"key":"R18-20260627","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1460-9592.2009.03055.x","article-title":"Anesthesia and perioperative medical management of children with spinal muscular atrophy.","volume":"19","author":"Graham","year":"2009","journal-title":"Paediatr Anaesth"},{"key":"R19-20260627","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"R21-20260627","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.1460-9592.2003.01042.x","article-title":"Difficult airway in a child with spinal muscular atrophy type I.","volume":"13","author":"Arima","year":"2003","journal-title":"Paediatr Anaesth"},{"key":"R22-20260627","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bja.2018.04.013","article-title":"Airway management in paediatric anaesthesia in Europe-insights from APRICOT (Anaesthesia Practice In Children Observational Trial): a prospective multicentre observational study in 261 hospitals in Europe.","volume":"121","author":"Engelhardt","year":"2018","journal-title":"Br J Anaesth"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000008155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:30:53Z","timestamp":1787747453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000008155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":21,"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000008155","relation":{},"ISSN":["0003-2999","1526-7598"],"issn-type":[{"value":"0003-2999","type":"print"},{"value":"1526-7598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]}}}